Tuesday, January 31, 2023
THE SENIOR HEALTH LETTER
No Result
View All Result
  • Home
  • Home Care
  • Elder Care
  • Wellness
  • Dementia
  • Caregivers
  • Alzheimer’s
  • Assisted living
  • Mindfulness
  • Seniors advocate
The Senior Health Letter
No Result
View All Result
Home Alzheimer's

Cutting-edge nanotechnology could lead to Alzheimer’s disease test

Delmar by Delmar
March 18, 2021
in Alzheimer's
0
Cutting-edge nanotechnology could lead to Alzheimer’s disease test
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter


Cutting-edge nanotechnology could lead to Alzheimer’s disease test
© iStock-haydenbird

A bunch of scientists have used cutting-edge nanotechnology to extract blood sign of neurodegeneration, which they hope could allow a test for early Alzheimer’s disease.

The workforce on the University of Manchester has performed a groundbreaking research wherein they’ve found beforehand unseen blood biomarkers that could doubtlessly be used to test for Alzheimer’s disease years earlier than signs seem. The nanotechnology used has been uniquely developed and patented by the Nanomedicine Lab in Manchester.

Professor Nigel Hooper, Associate Vice-President for Research and Director of Dementia Research at The University of Manchester stated: “The know-how developed opens up new potentialities for the event of novel multi-analyte blood assessments to predict the onset and growth of a variety of neurodegenerative issues.”

For the research, which has been funded by the Medical Research Council and revealed in ACS Nano, the workforce extracted blood indicators of neurodegeneration in a mouse mannequin of Alzheimer’s disease.

Testing for Alzheimer’s

There is nice potential for blood assessments that may seize indicators of neurodegeneration to assist sufferers obtain efficient therapy and higher handle their situation earlier than vital injury happens. Currently, Alzheimer’s disease is recognized utilizing mind scans, which may solely be performed as soon as somebody exhibits signs of the situation – by which period it’s too late to present efficient therapy.

Currently, detecting blood biomarkers for the situation is tough as their ranges are extraordinarily minute, nonetheless the know-how that has been developed by the workforce permits low blood indicators to be magnified and analysed.

Dr Marilena Hadjidemetriou, the lead researcher of the research and Lecturer in Nano-omics stated: “Hidden info in blood is probably going to echo the advanced cascade of occasions occurring within the mind of Alzheimer’s disease sufferers. We needed to engineer a nanotechnology blood-mining platform so as to uncover this info and determine early indicators of Alzheimer’s disease on the pre-disease state – earlier than the onset of amyloid plaque formation within the mind.’’

Detecting biomarkers

Amyloid plaques are poisonous to nerve cells and are a trademark of Alzheimer’s disease.  The workforce employed nanotechnology so as to improve the sensitivity of mass spectrometry, a proteomic approach at the moment used to analyse the patterns of proteins in blood, and used tiny nano-sized spheres, known as liposomes, as a instrument to discover disease particular proteins from blood.

When injected in mice with Alzheimer’s disease, nanoparticles spontaneously picked up a whole bunch of neurodegeneration-associated proteins onto their surfaces. The nanoparticles have been then retrieved intact from blood circulation and the molecular signatures on their floor have been analysed.

Professor Kostas Kostarelos, Professor of Nanomedicine stated: “This research was somewhat like a fishing expedition: we didn’t know what was beneath the floor of the ocean. The nano-tool we developed allowed us to see deeper into the blood proteome, figuring out proteins of curiosity which are straight related to neurodegeneration processes within the mind, amongst 1000’s of different blood-circulating molecules.

“We hope that these early warning indicators of Alzheimer’s disease could at some point be developed right into a blood test and we’re actively in search of validation of those signatures in human blood.’’

Tracking the protein ranges at totally different phases of Alzheimer’s disease allowed the workforce to determine advanced disease-monitoring patterns.

Dr Catherine B. Lawrence, Senior Lecturer on the Division of Neuroscience and Experimental Psychology stated: “We have been extraordinarily within the fluctuation of protein ranges at totally different disease phases – from the pre-diseased state to the intermediate state between amyloidopathy and cognitive signs and at last symptomatic disease. These findings point out that single time level blood biomarker discovery research present solely a snapshot of the blood proteome.

‘’This could clarify beforehand reported inconsistent outcomes and the shortage of clinically-used blood-based biomarkers for Alzheimer’s disease.’’




Subscribe to our newsletter








Source link

Tags: AlzheimersCuttingedgeDiseaseLeadNanotechnologytest
Advertisement Banner
Previous Post

The most luxurious wellness resorts around the globe – Emirates Woman

Next Post

Senior living occupancy declines slowed in February as COVID-19 cases fell and vaccinations rose: NIC – News

Delmar

Delmar

Next Post
Senior living occupancy declines slowed in February as COVID-19 cases fell and vaccinations rose: NIC – News

Senior living occupancy declines slowed in February as COVID-19 cases fell and vaccinations rose: NIC - News

Discussion about this post

Recommended

Melinda Gates takes on ‘crisis in caregiving’ – Yahoo! Voices

Melinda Gates takes on ‘crisis in caregiving’ – Yahoo! Voices

2 years ago
Aged Care Services Market Is Booming Globally by 2021 | Opportunity Analysis and Industry Forecast till 2028 | Benesse Style Care, Econ Healthcare Group – KSU

Aged Care Services Market Is Booming Globally by 2021 | Opportunity Analysis and Industry Forecast till 2028 | Benesse Style Care, Econ Healthcare Group – KSU

2 years ago

Don't Miss

(2021-2026) Nursing Home Beds Market Size, Demand Status | Global Industry Segment Analysis, Growing Status of Key Players

Advice You Need To Know About Personal Development

May 12, 2021
Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation

Advocate Aurora Enterprises acquires national leader in home care and wellness offerings Senior Helpers

April 1, 2021
‘I’m in jail’: BPS mothers and caregivers voice concerns with district reopening plans

‘I’m in jail’: BPS mothers and caregivers voice concerns with district reopening plans

April 1, 2021
As Loved Ones Reunite After A Year, Dementia Experts Offer These Tips

As Loved Ones Reunite After A Year, Dementia Experts Offer These Tips

April 1, 2021

Categories

  • Alzheimer's
  • Assisted living
  • Caregivers
  • Dementia
  • Elder Care
  • Home Care
  • Mindfulness
  • Seniors advocate
  • Uncategorized
  • Wellness

Follow us

Recent News

(2021-2026) Nursing Home Beds Market Size, Demand Status | Global Industry Segment Analysis, Growing Status of Key Players

Advice You Need To Know About Personal Development

May 12, 2021
Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation

Advocate Aurora Enterprises acquires national leader in home care and wellness offerings Senior Helpers

April 1, 2021
March 2021
S M T W T F S
 123456
78910111213
14151617181920
21222324252627
28293031  
    Apr »
  • About Us
  • Contact Us
  • Privacy & Policy

© 2021 The Senior health Letter

No Result
View All Result
  • Home
  • Home Care
  • Elder Care
  • Wellness
  • Dementia
  • Caregivers
  • Alzheimer’s
  • Assisted living
  • Mindfulness
  • Seniors advocate

© 2021 The Senior health Letter